ArticleJACC. Case reports2025
Cardiac Pseudomyogenic Hemangioendothelioma Presenting as Chest Pain in a Young Athlete.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPseudomyogenic hemangioendothelioma (PHE) is a rare tumor that can involve multiple tissues, including the heart. Its diagnosis is often elusive due to its rarity and atypical presentations, such as exertional chest pain in otherwise healthy individuals. CASE SUMMARY: A 40-year-old male athlete with no known comorbidities presented with chest pain during strenuous activities over 6 months. Exercise electrocardiogram demonstrated ischemic signs suggestive of left main coronary artery occlusion. Coronary computed tomography angiography revealed a heterogeneous mass partially occluding the circumflex artery and its branches. Additional radiological studies identified bilateral lung nodules, lytic bone lesions, and a muscle mass. A biopsy of the femur lesion confirmed the diagnosis of PHE. The patient experienced sudden death 3 months after diagnosis. DISCUSSION: This case highlights the diagnostic complexity of cardiac PHE, characterized by its rarity and atypical exertional chest pain, making it a notable contribution to the literature. TAKE-HOME MESSAGES: Consider rare cardiac masses like PHE in young patients with exertional chest pain mimicking coronary artery disease, as these can be aggressive and require timely detection. Utilize advanced imaging and immunohistochemistry for prompt diagnosis of infiltrative cardiac masses, enabling early intervention despite management challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.